Molecule Details
| InChIKey | ULGLMVSOOWNSNJ-UHFFFAOYSA-N |
|---|---|
| Compound Name | 5-(aminomethyl)-1-N-[2-[4-[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]piperidin-1-yl]ethyl]-3-N-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethyl]benzene-1,3-dicarboxamide |
| Canonical SMILES | NCc1cc(C(=O)NCCN2CCC(N3CCC(n4c(=O)[nH]c5ccccc54)CC3)CC2)cc(C(=O)NCCN2CCN(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)CC2)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.76 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile